Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Zhou Zhang"'
Autor:
Jun-Peng Xu, Rui-Xiang Zeng, Yu-Zhuo Zhang, Shan-Shan Lin, Jia-Wei Tan, Hai-Yue Zhu, Xiao-Yi Mai, Li-Heng Guo, Min-Zhou Zhang
Publikováno v:
Hypertension Research. 46:1009-1019
Autor:
Wen Zhang, Wei Chen, Yan Bi, Haiyan Cheng, Dalong Zhu, Bing Zhang, Wenyu Ni, Jiani Liu, Yingwen Miao, Zhou Zhang
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Wenyu Ni,1,* Zhou Zhang,1,* Bing Zhang,2 Wen Zhang,2 Haiyan Cheng,1 Yingwen Miao,1 Wei Chen,1 Jiani Liu,2 Dalong Zhu,1 Yan Bi1 1Department of Endocrinology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical Sc
Autor:
Yingwen Miao, Jin Wang, Bing Zhang, Wen Zhang, Xiang Xu, Yingjiao Hou, Qun Ding, Congcong Yu, Zhou Zhang, Yan Bi, Dalong Zhu
Publikováno v:
Diabetes/metabolism research and reviewsREFERENCES. 39(1)
This study aimed to explore the clinical features and spontaneous brain activity among patients with latent autoimmune diabetes in adults (LADA) and to investigate the relationship among these characteristics.We conducted a cross-sectional study usin
Autor:
Haiyan Cheng, Zhou Zhang, Bing Zhang, Wen Zhang, Jin Wang, Wenyu Ni, Yingwen Miao, Jiani Liu, Yan Bi
OBJECTIVE The comparative neuroprotective effects of different antidiabetes drugs have not been characterized in randomized controlled trials. Here, we investigated the therapeutic effects of liraglutide, dapagliflozin, or acarbose treatment on brain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c1300dddec890087c2ba9b19c832f2
https://doi.org/10.2337/figshare.19182023
https://doi.org/10.2337/figshare.19182023
Autor:
Zhong-Guo Sui, Bing Han, Guang-Wei Jia, Jian-Zhong Chen, Hai-Yan Shi, Yan-Xia Zhao, Bo-Hao Tang, Yue Zhou, Yue-Qin Han, Wei Zhao, Xin-Mei Yang, Johannes N. van den Anker, Xi-Ting Liu, Jian-Hua Dai, Fan Yang, Chuan-Zhou Zhang
Publikováno v:
British Journal of Clinical Pharmacology. 87:3292-3300
AIMS This open-label, phase I study evaluated the pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for the treatment of chemotherapy-induced neutropenia in children with acute leukaemia. M
Autor:
Junyi Ye, Shanai Song, Haiwei Du, Zhou Zhang, Haiyan Li, Ning Liu, Zimin Liu, Xiaoxiao Li, Lu Zhang, Mingpeng Shi
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose The identification of HER2 overexpression in a subset of gastric adenocarcinoma (GA) patients represents a significant step forward in unveiling the molecular complexity of this disease. The predictive and prognostic value of HER2 amplificati
Autor:
Zhou Zhang, Yanqun Song, Rudyard Chiu, Li Li, Xingyu Lu, Wei Zhang, Chang Chen, Miao Xu, Liyuan Han, Chuan He, Chang Zeng, Shiwei Duan
Publikováno v:
Genomics. 113:79-87
Diabetic retinopathy (DR) is a common microvascular complication that may cause severe visual impairment and blindness in patients with type 2 diabetes mellitus (T2DM). Early detection of DR will expand the range of potential treatment options and en
Autor:
Yi-Peng Pan, Wen-Dong Chen, Zhou Zhang, Ji-Hao Shi, Ying Chen, Qian Cao, Xiao-Li Chen, Hao Fang, Liang Luo
Publikováno v:
World Journal of Gastroenterology
Background Infliximab was the first approved biologic treatment for moderate to severe Crohn's disease (MS-CD) in China. However, the cost-effectiveness of infliximab maintenance therapy (IMT) for MS-CD relative to conventional maintenance therapy re
Autor:
Jason Karpus, Sheng Zhang, Chuan He, Marija Dobratic, Mark A. Applebaum, Wei Zhang, Alexandre Chlenski, Erin K. Barr, Emma Wilkinson, Lucy A. Godley, Susan L. Cohn, Barbara E. Stranger, Elizabeth A. Sokol, Robert L. Grossman, Meritxell Oliva, Diana C. West-Szymanski, Helen R. Salwen, Zhou Zhang
Publikováno v:
Clin Cancer Res
Purpose: 5-Hydroxymethylcytosine (5-hmC) is an epigenetic marker of open chromatin and active gene expression. We profiled 5-hmC with Nano-hmC-Seal technology using 10 ng of plasma-derived cell-free DNA (cfDNA) in blood samples from patients with neu
Autor:
Charles M. Balch, Zhou Zhang, Hsiaopei Mok, Guochun Zhang, Liping Guo, Chongyang Ren, Bo Chen, Minghan Jia, Guangnan Wei, Yulei Wang, Kai Li, Jiali Lin, Cheukfai Li, Lingzhu Wen, Ning Liao, Xiaoqing Chen, Li Cao
Publikováno v:
Cancer Research. 80:P4-09
Purpose: Somatic alterations of PIK3CA gene is an important therapeutic target in breast cancer (BC). The PI3Kα-specific inhibitor alpelisib was remarkably active against PIK3CA-mutated, HR-positive/HER2-negative BC in the SOLAR-1 trial. We hypothes